BRCA1/2 germline missense mutations: a systematic review-Reference-Cited by-同舟云学术

BRCA1/2 germline missense mutations: a systematic review

Published:2018-05 Issue:3 Volume:27 Page:279-286
ISSN:0959-8278
Container-title:European Journal of Cancer Prevention
language:en
Short-container-title:

Author:

Corso Giovanni,Feroce Irene,Intra Mattia,Toesca Antonio,Magnoni Francesca,Sargenti Manuela,Naninato Paola,Caldarella Pietro,Pagani Gianmatteo,Vento Annarita,Veronesi Paolo,Bonanni Bernardo,Galimberti Viviana

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Public Health, Environmental and Occupational Health,Oncology,Epidemiology

Reference33 articles.

1. BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy;Ang;Cancer Epidemiol Biomarkers Prev,2007

2. Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography;Arnold;J Chromatogr B Analyt Technol Biomed Life Sci,2002

3. A high frequency of germline BRCA1/2 mutations in western Sweden detected with complementary screening techniques;Bergman;Fam Cancer,2005

4. Characterization of an Italian founder mutation in the RING-finger domain of BRCA1;Caleca;PLoS One,2014

5. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families;Cherbal;Dis Markers,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in breast cancer research using CRISPR/Cas9 system;Nano Select;2024-05-26

2. Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing;Genes;2024-02-08

3. Functional analyses of rare germline BRCA1 variants by transcriptional activation and homologous recombination repair assays;BMC Cancer;2023-04-21

4. Risk and incidence of breast cancer in transgender individuals: a systematic review and meta-analysis;European Journal of Cancer Prevention;2023-02-16

5. Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer;Breast Cancer Research and Treatment;2022-11-04